173 related articles for article (PubMed ID: 31780764)
21. Relationship between mucosal healing by tacrolimus and relapse of refractory ulcerative colitis: a retrospective study.
Ito A; Murasugi S; Omori T; Nakamura S; Tokushige K
BMC Gastroenterol; 2020 Jun; 20(1):203. PubMed ID: 32590945
[TBL] [Abstract][Full Text] [Related]
22. Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis.
Mohammed Vashist N; Samaan M; Mosli MH; Parker CE; MacDonald JK; Nelson SA; Zou GY; Feagan BG; Khanna R; Jairath V
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011450. PubMed ID: 29338066
[TBL] [Abstract][Full Text] [Related]
23. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
[TBL] [Abstract][Full Text] [Related]
24. A novel endoscopic imaging system for quantitative evaluation of colonic mucosal inflammation in patients with quiescent ulcerative colitis.
Honzawa Y; Matsuura M; Higuchi H; Sakurai T; Seno H; Nakase H
Endosc Int Open; 2020 Jan; 8(1):E41-E49. PubMed ID: 31921983
[No Abstract] [Full Text] [Related]
25. Tacrolimus for remission induction in ulcerative colitis: Mayo endoscopic subscore 0 and 1 predict long-term prognosis.
Ikeya K; Sugimoto K; Kawasaki S; Iida T; Maruyama Y; Watanabe F; Hanai H
Dig Liver Dis; 2015 May; 47(5):365-71. PubMed ID: 25682993
[TBL] [Abstract][Full Text] [Related]
26. Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD.
Molander P; Sipponen T; Kemppainen H; Jussila A; Blomster T; Koskela R; Nissinen M; Rautiainen H; Kuisma J; Kolho KL; Färkkilä M
J Crohns Colitis; 2013 Oct; 7(9):730-5. PubMed ID: 23182163
[TBL] [Abstract][Full Text] [Related]
27. Mucosal Healing in Ulcerative Colitis--When Zero is Better.
Boal Carvalho P; Dias de Castro F; Rosa B; Moreira MJ; Cotter J
J Crohns Colitis; 2016 Jan; 10(1):20-5. PubMed ID: 26438714
[TBL] [Abstract][Full Text] [Related]
28. Different Profile of Efficacy of Thiopurines in Ulcerative Colitis and Crohn's Disease.
Rispo A; Testa A; De Palma GD; Donetto S; Diaferia M; Musto D; Nardone O; Maione F; Caporaso N; Castiglione F
Inflamm Bowel Dis; 2015 Nov; 21(11):2570-5. PubMed ID: 26222340
[TBL] [Abstract][Full Text] [Related]
29. Clinical Study of the Relation between Mucosal Healing and Long-Term Outcomes in Ulcerative Colitis.
Yokoyama K; Kobayashi K; Mukae M; Sada M; Koizumi W
Gastroenterol Res Pract; 2013; 2013():192794. PubMed ID: 23762033
[TBL] [Abstract][Full Text] [Related]
30. Mean Corpuscular Volume to White Blood Cell Ratio for Thiopurine Monitoring in Pediatric Inflammatory Bowel Disease.
Kandavel P; Eder SJ; Newman NE; Waljee AK; Whitfield EP; Adler J
J Pediatr Gastroenterol Nutr; 2019 Jul; 69(1):88-94. PubMed ID: 30747813
[TBL] [Abstract][Full Text] [Related]
31. Impact of immunomodulator use on treatment persistence in patients with ulcerative colitis: A claims database analysis.
Kobayashi T; Udagawa E; Uda A; Hibi T; Hisamatsu T
J Gastroenterol Hepatol; 2020 Feb; 35(2):225-232. PubMed ID: 31397010
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of Dose Escalation of Oral 5-Aminosalicylic Acid for Ulcerative Colitis With a Mayo Endoscopic Subscore of 1: An Open Label Randomized Controlled Trial.
Fukuda T; Aoki Y; Kiyohara H; Yokoyama A; Nakazawa A; Yoshimatsu Y; Sugimoto S; Nanki K; Mikami Y; Fukuhara K; Mizuno S; Sujino T; Mutaguchi M; Takabayashi K; Morohoshi Y; Hosoda Y; Ogata H; Iwao Y; Naganuma M; Kanai T
Inflamm Bowel Dis; 2024 Apr; ():. PubMed ID: 38655866
[TBL] [Abstract][Full Text] [Related]
33. Serum amyloid A is a better predictive biomarker of mucosal healing than C-reactive protein in ulcerative colitis in clinical remission.
Wakai M; Hayashi R; Tanaka S; Naito T; Kumada J; Nomura M; Takigawa H; Oka S; Ueno Y; Ito M; Chayama K
BMC Gastroenterol; 2020 Apr; 20(1):85. PubMed ID: 32245401
[TBL] [Abstract][Full Text] [Related]
34. Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitis.
Viscido A; Valvano M; Stefanelli G; Capannolo A; Castellini C; Onori E; Ciccone A; Vernia F; Latella G
BMC Gastroenterol; 2022 Mar; 22(1):92. PubMed ID: 35240984
[TBL] [Abstract][Full Text] [Related]
35. Applicability of endoscopic indices in the determination of disease activity in patients with ulcerative colitis.
Kucharski M; Karczewski J; Mańkowska-Wierzbicka D; Karmelita-Katulska K; Grzymisławski M; Kaczmarek E; Iwanik K; Rzymski P; Swora-Cwynar E; Linke K; Dobrowolska A
Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):722-30. PubMed ID: 26894632
[TBL] [Abstract][Full Text] [Related]
36. Anti-Tumor Necrosis Factor-Alpha Withdrawal in Children With Inflammatory Bowel Disease in Endoscopic and Histologic Remission.
Scarallo L; Bolasco G; Barp J; Bianconi M; di Paola M; Di Toma M; Naldini S; Paci M; Renzo S; Labriola F; De Masi S; Alvisi P; Lionetti P
Inflamm Bowel Dis; 2022 Feb; 28(2):183-191. PubMed ID: 33835155
[TBL] [Abstract][Full Text] [Related]
37. The Ulcerative Colitis Endoscopic Index of Severity More Accurately Reflects Clinical Outcomes and Long-term Prognosis than the Mayo Endoscopic Score.
Ikeya K; Hanai H; Sugimoto K; Osawa S; Kawasaki S; Iida T; Maruyama Y; Watanabe F
J Crohns Colitis; 2016 Mar; 10(3):286-95. PubMed ID: 26581895
[TBL] [Abstract][Full Text] [Related]
38. Development and Validation of a Confocal Laser Endomicroscopy-Based Score for In Vivo Assessment of Mucosal Healing in Ulcerative Colitis Patients.
Hundorfean G; Chiriac MT; Mihai S; Hartmann A; Mudter J; Neurath MF
Inflamm Bowel Dis; 2017 Dec; 24(1):35-44. PubMed ID: 29272480
[TBL] [Abstract][Full Text] [Related]
39. Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventional therapy.
Colombel JF; Jharap B; Sandborn WJ; Feagan B; Peyrin-Biroulet L; Eichner SF; Robinson AM; Mostafa NM; Zhou Q; Thakkar RB
Aliment Pharmacol Ther; 2017 Jan; 45(1):50-62. PubMed ID: 27883215
[TBL] [Abstract][Full Text] [Related]
40. Indigo naturalis is effective even in treatment-refractory patients with ulcerative colitis: a post hoc analysis from the INDIGO study.
Naganuma M; Sugimoto S; Fukuda T; Mitsuyama K; Kobayashi T; Yoshimura N; Ohi H; Tanaka S; Andoh A; Ohmiya N; Saigusa K; Yamamoto T; Morohoshi Y; Ichikawa H; Matsuoka K; Hisamatsu T; Watanabe K; Mizuno S; Abe T; Suzuki Y; Kanai T;
J Gastroenterol; 2020 Feb; 55(2):169-180. PubMed ID: 31529220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
